Caroline Diorio, MD¹, Regina M. Myers, MD², Anastasia Frank-Kamenetski^3*, Rawan Shraim^2*, Amanda M. Dinofia, MD, MSCE^1*, Zachary Martinez^1*, Ohaila Mustafa^3*, Joseph A Fraietta, PhD^4*, Vanessa Gonzalez^5*, Vivian Yi^6*, Lahari Uppuluri^2*, Haley Newman, MD¹, Edward Behrens^5*, Carl June, MD⁷, Scott Canna^3*, Stephan Grupp, MD, PhD¹ and David T. Teachey, MD¹

¹Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA
²Children's Hospital of Philadelphia, Philadelphia, PA
³Children's Hospital of Philadelphia, Philadelphia
⁴Center for Cellular Immunotherapies, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA
⁵University of Pennsylvania, Philadelphia, PA
⁶University of Pennsylvania, Philadelphia
⁷Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA

Howell Moffett^1*, Brian Weitzner^2*, Thaddeus Davenport^2*, Leah Tait^2*, Tina Tan^2*, Laura Baker^2*, John Crowl^2*, Willimark Obenza^2*, Bradley Hammerson^2*, Robin Kirkpatrick^2*, Paul Sample^2*, Lesley Jones^2*, Erik Hermans^2*, Robert Langan^2*, Kevin Haworth^2*, Scott Boyken^2*, Aaron Foster² and Marc Lajoie^2*

¹Outpace Bio, Seattle, WA
²Outpace Bio, Seattle

Juan Roberto Rodriguez-Madoz, PhD^1,2*, Lorea Jordana-Urriza^1*, Guillermo Serrano, PhD^3*, Aina Oliver Caldes, MD^4*, Maria Erendira Calleja-Cervantes, PhD^1,3*, Patxi San-Martin^1*, Amaia Vilas-Zornoza^1,2*, Asier Ullate-Agote^1*, Aintzane Zabaleta^1,2,5*, Diego Alignani^1,2,5*, Teresa Lozano, PhD^6*, Valentin Cabanas Perianes, MD^7*, Juan Luis Reguera, MD^8*, Almudena Navarro-Bailon^9*, Marta Español-Rego, MD, PhD^10*, Mariona Pascal, PhD^10*, Jose Maria Moraleda, MD, PhD^7*, Jose A. Perez-Simon, MD, PhD^8*, Maria Victoria Mateos, MD, PhD^2,9, Fermin Sanchez-Guijo Martin, MD, PhD^2,11*, Alvaro Urbano-Ispizua Sr., MD⁴, Manel Juan, MD, PhD^10*, Ana Alfonso Pierola, M.D., Ph.D.^12,13,14*, Jose J. Rifon, M.D.^2,12,13*, Paula Rodriguez Otero, MD, PhD^2,12,13*, Bruno Paiva^1,2,13,15*, Susana Inogés, MD, PhD^2,12,16*, Ascensión López-Díaz De Cerio^2,12,16*, Juan J Lasarte, PhD^6,13*, Jesús San Miguel, MD, PhD^1,2,13,17*, Carlos Fernández de Larrea^4*, Mikel Hernaez, PhD^2,3,18* and Felipe Prosper, MD, PhD^1,2,12,13

¹Hemato-Oncology Program. Cima Universidad de Navarra. IdiSNA., Pamplona, Spain
²Centro de Investigacion Biomedica en Red de Cancer (CIBERONC)., Madrid, Spain
³Computational Biology Program. Cima Universidad de Navarra. IdiSNA., Pamplona, Spain
⁴Department of Hematology. Hospital Clinic de Barcelona. IDIBAPS. Universidad de Barcelona., Barcelona, Spain
⁵Flow Cytometry Core. Cima Universidad de Navarra. IdiSNA., Pamplona, Spain
⁶Immunology and Immunotherapy Program. Cima Universidad de Navarra. IdiSNA., Pamplona, Spain
⁷Department of Hematology, IMIB-Virgen de la Arrixaca University Hospital. University of Murcia., Murcia, Spain
⁸Department of Hematology, University Hospital Virgen del Rocio-IBIS. Universidad de Sevilla., Sevilla, Spain
⁹Hematology Department, IBSAL-University Hospital of Salamanca. University of Salamanca., Salamanca, Spain
¹⁰Department of Immunology. Hospital Clinic de Barcelona. IDIBAPS. Universidad de Barcelona., Barcelona, Spain
¹¹Hospital Universitario de Salamanca, Instituto de Investigacion Biomedica de Salamanca (IBSAL), Centro de Investigación del Cancer (IBMCC-USAL, CSIC), Salamanca, Spain
¹²Hematology and Cell Therapy Department. Clinica Universidad de Navarra, IdiSNA., Pamplona, Spain
¹³Cancer Center Universidad de Navarra (CCUN)., Pamplona, Spain
¹⁴Centro de Investigacion Biomedica en Red de Cancer (CIBERONC), Madrid, Spain
¹⁵Flow Cytometry Core, Centre for Applied Medical Research (CIMA), Instituto de Investigaciones Sanitarias de Navarra (IdiSNA), Cancer Center Clinica Universidad de Navarra (CCUN), Pamplona, Spain
¹⁶Immunology and Immunotherapy Department. Clinica Universidad de Navarra., Pamplona, Spain
¹⁷Cancer Center Clínica Universidad de Navarra (CCUN), CIMA, CIBERONC, IDISNA, Pamplona, Spain
¹⁸Data Science and Artificial Intelligence Institute (DATAI). Universidad de Navarra., Pamplona, Spain

Lixia Ma^1*, Xiaoyan Ke^2,3* and Kai HU^1*

¹Department of Lymphoma and Myeloma Research Center, Beijing Gobroad Boren Hospital, Beijing, China
²Peking University Third Hospital, Beijing, China
³Department of Lymphoma and Myeloma Research Center, Beijing Gobroad Boren Hospital, Beijing, China

Laura Volta^1,2*, Renier Myburgh, PhD^1*, Christian Pellegrino, PhD^1,2*, Christian Koch, MD^1*, Monique Maurer, BSc^1*, Francesco Manfredi, MD PhD^1*, Mara Hofstetter, MSc^1*, Anne Kaiser, MD^1*, Florin Schneiter, MSc^3*, Jan Müller, MD PhD^1*, Marco M. Bühler, MD^4*, Roberto De Luca, PhD^5*, Nicholas Favalli, PhD^6*, Chiara F. Magnani, PhD^1*, Timm Schroeder^7*, Dario Neri, PhD^2,5* and Markus G. Manz, MD^1,8

¹University and University Hospital Zurich, Zurich, Switzerland
²ETH Zurich, Zurich, Switzerland
³ETH Zurich, Basel, Switzerland
⁴University Hospital Zurich, Zurich, Switzerland
⁵Philochem AG, Otelfingen, Switzerland
⁶Philogen AG, Zurich, Switzerland
⁷Department of Biosystems Sciences and Engineering, ETH Zurich, Basel, Switzerland
⁸Comprehensive Cancer Center Zurich, Zurich, Switzerland

Dustin A Cobb, PhD^*, Lixia Liu^*, Philip Mollica III^*, Barbara Dziegielewska^* and Daniel W. Lee, MD

Department of Pediatrics, University of Virginia, Charlottesville, VA

Adam Johnson, PhD^1*, Hallee Wright^2*, Xiaomeng Hu, PhD^1*, Jeremy Kinder, PhD^2*, Neal van Hoeven, PhD^1*, Ouwen Liang, BS^1*, Brian Granger, BS^1*, Tori Duback, MS^3*, Chris Baldeviano^3*, Sundeep Chandra^3*, Trevor McGill^3*, Boris Gorovits^1*, Shannon Joyce^1*, Sam Crocker^3*, Anna Liang^1*, Carrie Rocca^3*, Jenny Migliaccio^3*, Prasanna Kumar^3*, Vasily Vagin^4*, Kerrie Enger^4*, Chi Young^5*, Andrew McAlister^2*, Sonja Schrepfer^1* and Terry J. Fry, MD¹

¹Sana Biotechnology, Seattle, WA
²Sana Biotechnology, Seattle
³Sana Biotechnology, Cambridge
⁴Sana Biotechnology, Cambridge, MA
⁵Sana Biotechnology, South San Francisco, CA

Kenneth A. Dietze, BS^1*, Michael L. Olson, PhD^2*, Etse Gebru, BS^3*, Djordje Atanackovic, MD³, Aaron P. Rapoport, MD³ and Tim Luetkens, MD^1,3*

¹Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD
²Division of Hematologic Neoplasia, Dana Farber Cancer Institute, Boston, MA
³University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD

Viktoria Blumenberg, MD^1,2,3,4, Maryam Kazerani, Ph.D.^2*, Stephan Baumann^5*, Tobias Straub, Ph.D.^6*, Francesco Corrado, MD^2*, Jan Wulf^2*, Galina Busch^5*, Kai Rejeski, MD^3,4,5,7, Lisa Frölich^8,9*, Christian Schmidt, MD^9*, Michael von Bergwelt-Baildon^1,8,10*, Veit L. Buecklein, MD^1,2,3* and Marion Subklewe, MD^4,5,11,12

¹Department of Medicine III, LMU University Hospital, LMU Munich, Munich, Germany
²Laboratory for Translational Cancer Immunology, Gene Center, LMU Munich, Munich, Germany
³Bavarian Cancer Research Center (BZKF), Munich, Germany
⁴German Cancer Consortium (DKTK), Partner Site Munich, Munich, Germany
⁵Laboratory for Translational Cancer Immunology, LMU Gene Center, LMU Munich, Munich, Germany
⁶Core Facility Bioinformatics, LMU Biomedical Center, LMU Munich, Munich, Germany
⁷LMU University Hospital, Munich, Germany
⁸German Cancer Consortium (DKTK), partner site Munich, Munich, Germany
⁹Department of Medicine III, University Hospital, LMU Munich, Munich, Germany
¹⁰Bavarian Cancer Research Center (BZKF), partner site Munich, Munich, Germany
¹¹Bavarian Cancer Research Center (BZKF), R/R ALL Study Group, Bavaria, Germany
¹²Department of Medicine III, LMU University Hospital, LMU Munich, Muenchen, Bavaria, Germany

Leonard Leong, PhD^1,2*, Mansi Narula^1*, Helen Elisabeth Heslop¹, Malcolm K. Brenner, M.D., Ph.D.^1*, Maksim Mamonkin, Ph.D¹ and Norihiro Watanabe, PhD^1*

¹Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, TX
²Biotherapeutics Development, Bioprocessing Technology Institute (BTI), Agency for Science, Technology and Research (A*STAR), Singapore, Singapore

Madeline Lauener, BSc¹, Kirk R. Schultz^2,3, Sayeh Abdossamadi^4*, Elena Ostroumov^5* and Megan Levings^6*

¹University of British Columbia, Vancouver, Canada
²University of British Columbia, Vancouver, BC, Canada
³B.C. Children's Hospital, Vancouver, BC, Canada
⁴BC Children's Hospital Research Institute, Vancouver, BC, CAN
⁵BC Children's Hospital Research Institute, Vancouver, Canada
⁶University of British Columbia, Canada, Vancouver, BC, CAN

Xu Beilei^1*, Chao Zhang^2*, Junxiao Gao^2*, Zhu Li^2*, Shengzhen Ding^2*, Li Liu^2*, Hang Zhang^2*, Lulu Lyu^1* and Li Zhou, MD^1*

¹Juventas Cell Therapy Ltd., Beijing, China
²Juventas Cell Therapy Ltd., Shanghai, China

Ella C Troy, BSc^1*, Yasemin Sezgin, MS^1*, Marcelo De Souza Pereira^2,3*, Joseph Caporale^4*, Gregory K Behbehani, MD, PhD⁵, Justin Lyberger^5*, Dean Anthony Lee, MD, PhD^6,7,8,9 and Meisam Naeimi Kararoudi, PhD, DVM^1,8,10

¹Center for Childhood Cancer, Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, OH
²1Center for Childhood Cancer and Blood Disease, Abigail Wexner Research Institute, Nationwide Children's Hospital, Center For Childhood Cancer and Blood Diseases, Abigail Wexner Research Institut, Columbus, OH
³Center for Childhood Cancer and Blood Diseases, Abigail Wexner Research Institute, Nationwide Children's Hospital, Columbus, OH
⁴Childhood Cancer, Nationwide Children's Hospital, Columbus
⁵Division of Hematology, Department of Internal Medicine, The Ohio State University Wexner Medical Center, Columbus, OH
⁶Center for Childhood Cancer, Abigail Wexner Research Institute, Nationwide Children’s Hospital, Columbus, OH
⁷Division of Hematology/Oncology/BMT, Nationwide Children's Hospital, Columbus, OH
⁸Department of Pediatrics, The Ohio State University, Columbus, OH
⁹Hem/Onc/BMT, Nationwide Children’s Hospital, Columbus, OH
¹⁰CRISPR/Gene Editing Core, Department of Pediatrics, Abigail Wexner Research Institute at Nationwide Children’s Hospital, The Ohio State University, College of Medicine, Columbus

Lisa Rohrbacher, MSc^1,2*, Daniel Nixdorf, MSc^1,2*, Helena Stadler, M.Sc.^1,2*, Bettina Brauchle, Ph.D.^1,2*, Florian Märkl, M.Sc.^3*, Nora Philipp^1,2*, Gerulf Hänel, Ph.D.^1,2*, Anetta Marcinek, M.Sc.^1,2*, Maryam Kazerani, Ph.D.^1,2*, Alica Joana Emhardt, MD^2*, Giulia Magno, MD^2*, Rebecca L. Goldstein, Ph.D.^4*, Tobias Straub, Ph.D.^5*, Sebastian Kobold, MD, Prof^3,6,7*, Tara L. Chapman-Arvedson, Ph.D.^4*, Veit L. Buecklein, MD^1,2* and Marion Subklewe, MD^1,7,8

¹Laboratory for Translational Cancer Immunology, Gene Center, LMU Munich, Munich, Germany
²Department of Medicine III, LMU University Hospital, LMU Munich, Munich, Germany
³Center for Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany
⁴AMGEN Research, AMGEN Inc., South San Francisco, CA
⁵Core Facility Bioinformatics, LMU Biomedical Center, LMU Munich, Munich, Germany
⁶Einheit für Klinische Pharmakologie (EKLiP), Helmholtz Munich, Research Center for Environmental Health (HMGU), Neuherberg, Germany
⁷German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany
⁸Department of Medicine III, LMU University Hospital, LMU Munich, Muenchen, Bavaria, Germany

Lorenzo Lindo, BSc^1,2, Erin Meermeier, PhD^3,4*, Lauren H Wilkinson, HBMSc^2*, Silvia Selleri, PhD^2*, Mehdi Arbabi Ghahroudi, PhD^5*, Scott McComb, PhD^5,6*, P. Leif Bergsagel, MD⁴, Marta Chesi, PhD⁴, Laura Evgin, PhD^7,8*, Daniel D Waller, PhD^2* and Kevin A Hay, MD, MSc, FRCPC^1,2,9

¹Department of Medicine, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada
²Terry Fox Laboratory, BC Cancer Research Institute, Vancouver, BC, Canada
³Department of Immunology, Mayo Clinic, Scottsdale, AZ
⁴Division of Hematology/Oncology, Department of Internal Medicine, Mayo Clinic, Scottsdale, AZ
⁵University of Ottawa, Ottawa, ON, Canada
⁶National Research Council of Canada, Ottawa, ON, Canada
⁷Department of Medical Genetics, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada
⁸Michael Smith Genome Sciences Department, BC Cancer Research Institute, Vancouver, BC, Canada
⁹Leukemia/Bone Marrow Transplant Program of BC, Vancouver General Hospital, Vancouver, BC, Canada

Jamie Schafer^*, Justin Trombley^*, Benjamin Hallisey^*, Kunza Ahmad^*, Scott Clarkson^*, Thijs Udo^*, McKensie Collins^*, Laura Kehoe^*, Erica Hildebrand^*, Kaylie Schneider^*, Kuo-Chan Hung^*, Ricardo N Ramirez^*, Mary Morrison^*, Morgan Maeder^*, Sahar Abubucker^*, Ari Friedland^*, Pietro Spinelli^*, Vic Myer^* and Aron Jaffe^*

Chroma Medicine, Boston, MA

Holly Wobma, MD, PhD^1,2*, Jiayi Dong, BS^1*, Francesca Alvarez Calderon^1,3, Xianliang Rui, PhD^3*, Katherine Michaelis, MD, PhD^1,3*, Bruce R Blazar, MD⁴, Victor Tkachev, PhD^1,5*, Ulrike Gerdemann, MD^1,3 and Leslie Kean^1,3

¹Harvard Medical School, Boston, MA
²Division of Immunology, Boston Children's Hospital, Boston, MA
³Division of Hematology-Oncology, Boston Children's Hospital, Boston, MA
⁴Division of Pediatric Blood and Marrow Transplantation, University of Minnesota, Minneapolis, MN
⁵Center for Transplantation Sciences, Massachusetts General Hospital, Boston, MA

Semjon Willier, MD^1*, Julian Färber^2*, Theodora Ispyrlidou^2*, Dana Stenger^3*, Sophia LM Nikolaides^2*, Paulina Ferrada Ernst^2*, Annika E Peters, PhD^2*, Jonas Wilhelm^4*, Nadine Stoll^2*, Maike Breidenbach, MD^1*, Fiona AG Becker-Dettling^4*, Franziska Blaeschke⁴, Theresa Kaeuferle^4*, Abdallah AHA Yassin, PhD^2*, Christoph Klein⁴ and Tobias Feuchtinger, MD¹

¹Department of Pediatric Hematology, Oncology, Hemostaseology and Stem Cell Transplantation, Dr. von Hauner Children’s Hospital, University Hospital, LMU Munich, Munich, Germany
²Department of Pediatrics, Dr. von Hauner Children’s Hospital, University Hospital, LMU Munich, Munich, Germany
³Department of Pediatrics, Dr. von Hauner Children’s Hospital, University Hospital, LMU Munich, Muenchen, Germany
⁴Department of Pediatrics, Dr. von Hauner Children’s Hospital, LMU University Hospital, LMU Munich, Munich, Germany

Yingshuai Wang^1,2*, Wenjie Lu^1,2*, Lisa Rohrbacher, MSc^1,2*, Heinrich Flaswinkel, Dr.^3*, Alica Joana Emhardt, MD^1*, Giulia Magno, MD^1*, Sascha Haubner, MD^4*, Sebastian Kobold, MD, Prof^5,6,7*, Heinrich Leonhardt, Prof. Dr^3*, Karl-Peter Hopfner, Prof. Dr^2,8*, Dirk H Busch, MD^9*, Veit L. Buecklein, MD^1,2*, Daniel Nixdorf, MSc^1,2* and Marion Subklewe, MD^2,7,10

¹Department of Medicine III, LMU University Hospital, LMU Munich, Munich, Germany
²Laboratory for Translational Cancer Immunology, Gene Center, LMU Munich, Munich, Germany
³Faculty of Biology, LMU Munich, Munich, Germany
⁴Memorial Sloan Kettering Cancer Center, New York, NY
⁵Center for Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, LMU University Hospital, LMU Munich, Munich, Germany
⁶Einheit für Klinische Pharmakologie (EKLiP), Helmholtz Zentrum München, German Research Center for Environmental Health (HMGU), Neuherberg, Germany
⁷German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Heidelberg, Germany
⁸Department of Biochemistry, LMU Munich, Munich, Germany
⁹Institute for Medical Microbiology, Immunology and Hygiene, Technical University of Munich, Munich, Germany
¹⁰Department of Medicine III, LMU University Hospital, LMU Munich, Muenchen, Bavaria, Germany

Laura Contreras-Ruiz, PhD^1*, Barcley Pace, MS^1*, Dora E Kohnke, MS^1*, Lindsey Viruet, BS^1*, Melissa Adams^1*, John F Krisko, PhD^1*, Noah Leesnitzer, BS^1*, Marissa Velie, BS^1*, Sarah Tettamanti, PhD^2*, Ilaria Pisani, BS^2*, Giusi Melita, BS^2*, Andrea Biondi, MD^3,4, Alessandro Rambaldi, M.D.⁵, Irina Y Tcherepanova, PhD^1*, Renier Brentjens, MD PhD^6,7 and Charles A Nicolette, PhD^1*

¹CoImmune Inc, Durham, NC
²Tettamanti Center, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy
³Pediatrics, Fondazione IRCCS San Gerardo Dei Tintori, Monza, Italy
⁴School of Medicine and Surgery, University of Milano-Bicocca, Monza, Italy
⁵Department of Oncology and Hematology, University of Milan and Azienda Socio-Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy
⁶Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY
⁷Center for Cell Engineering, Sloan Kettering Institute, New York, NY

Xiaohui Si, PhD^1*, Mi Shao^2*, Xinyi Teng^2*, Yue Huang^3*, Tianning Gu^4*, Gang Xiao, PhD^5* and He Huang^6*

¹The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, AL, China
²Bone Marrow Transplantation Center, The First Affiliated Hospital, School of Med, Hangzhou, CHN
³The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
⁴Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
⁵School of Medicine, Zhejiang University, Hangzhou, China
⁶The First Affiliated Hospital, College of Medicine, Zhejiang University, Hematology, Hangzhou, AL, China

Xiaoli Mi, MD¹, Dennis Yuan, PhD^2,3*, Rebecca Murray, BS^4,5*, Jani Huuhtanen, M.D.^6,7,8,9*, Beatrice Zhang^1*, Jean Quentin^2,3*, Olga Shestova, PhD^10*, David L. Porter, MD^11,12, Satu Mustjoki, MD, PhD^6,8,9, Saar Gill, MD, PhD¹³ and Dan A. Landau, MD, PhD^4*

¹Memorial Sloan Kettering Cancer Center, New York, NY
²New York Genome Center, New York, NY
³Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY
⁴New York Genome Center, New York
⁵Sandra and Edward Meyer Cancer Center, Weill Cornell Medicine, New York
⁶Translational Immunology Research Program and Department of Clinical Chemistry and Hematology, University of Helsinki, Helsinki, Finland
⁷Department of Computer Science, Aalto University, Espoo, Finland
⁸Hematology Research Unit Helsinki, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland
⁹ICAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland
¹⁰Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
¹¹Abramson Cancer Center, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA
¹²Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania, Philadelphia, PA
¹³Center for Cellular Immunotherapies, University of Pennsylvania School of Medicine, Philadelphia, PA

Pengfei Jiang, PhD^1*, Shih-Ting Cao^1*, Haiying Wang, PhD^1*, Qinghui Xiong, PhD^2*, Mingyuan Gu^1*, Chengbing Fu^1*, Xiu Li^1*, Mian Zhang^1*, Na Li^1*, Jing Li^1*, Xin Xu^1* and Yiwei Gong^1*

¹Shanghai HRAIN Biotechnology Co.,Ltd., Shanghai, China
²Shanghai HRAIN Biotechnology Co.,Ltd., Shanghai, AL, China

Salvatore Fiorenza, MBBS, PhD, BSc, FRACP, FRCPA, MPH^1,2, Ye Zheng, PhD^3*, Jay Sarthy, MD PhD^4*, Alyssa Sheih, PhD^3*, Erik L Kimble, MD³, Delaney Kirchmeier, BS^3*, Derek Janssens, PhD^5*, Tinh-Doan Phi^3*, Jordan Gauthier, MD, MSc³, Alexandre V Hirayama, MD^3*, Qian Wu^6*, Raphael Gottardo^7*, Stanley R. Riddell, MD⁸, David G Maloney, MD, PhD³, Steven Henikoff, PhD^5* and Cameron J. Turtle, MBBS, PhD^9*

¹Faculty of Medicine and Health, University of Sydney, Balwyn North, VIC, Australia
²Molecular Oncology and Cancer Immunology, Epworth HealthCare, Richmond, VIC, Australia
³Fred Hutchinson Cancer Center, Seattle, WA
⁴Seattle Children's Research Institute, Seattle, WA
⁵Basic Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA
⁶Fred Hutchinson Cancer Center, Suzhou, Jiangsu, China
⁷Swiss Institute of Bioinformatics, Lausanne, Switzerland
⁸Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA
⁹Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia

Yuzhe SHI^1*, Ivan S Kotchetkov, MD^2*, Sophie Alexandra Hanina, BMBCh, PhD^2* and Michel Sadelain, MD PhD²

¹Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, NEW YORK, NY
²Center for Cell Engineering, Memorial Sloan Kettering Cancer Center, New York, NY

Chaja F. Jacobs^1,2,3,4*, Helga Simon-Molas, PhD^1,2,3,5*, Gaspard Cretenet, PhD^1,2,3,5*, Miriam Gutschow, PhD^6*, Amy Chattin^6*, Garrett Collett^6*, Lucrezia Colonna, PhD^6*, Fleur S. Peters, PhD^1,2,3,5,7* and Arnon P. Kater, MD, PhD^1,2,3,7,8

¹Cancer Immunology, Amsterdam Institute for Infection and Immunity, Amsterdam, Netherlands
²Cancer Immunology, Cancer Center Amsterdam, Amsterdam, Netherlands
³Hematology, Amsterdam UMC location University of Amsterdam, Amsterdam, Netherlands
⁴Experimental Immunology, Amsterdam UMC, Amsterdam, Netherlands
⁵Experimental Immunology, Amsterdam UMC location University of Amsterdam, Amsterdam, Netherlands
⁶Bristol Myers Squibb, Seattle, WA
⁷* Co-last author, Amsterdam, Netherlands
⁸Lymphoma and Myeloma Center Amsterdam, LYMMCARE, Amsterdam, Netherlands

Candela Ceballos Bolaños, MD^1*, Cristina Calviño^2*, Ana Alfonso Pierola, M.D., Ph.D.^3,4*, Patricia Jauregui^2*, Maria Erendira Calleja-Cervantes, PhD^5,6*, Patxi San-Martin^7*, Paula Rodríguez Márquez, PhD^8*, Ángel Martin Mallo^7*, Elena Iglesias^2*, Gloria Abizanda^7*, Saray Rodríguez Diaz^7*, Rebeca Martínez Turrillas^8*, Jorge Illarramendi Esteban, M.D^1*, Ana Margarita Redondo, M.D, PhD^9*, MC Viguria-Alegría, M.D, PhD^9*, Carlos Panizo, MD, PhD^10*, Jose J. Rifon, M.D.^3,8*, Sara Villar^11*, Juan J Lasarte, PhD^12,13*, Susana Inogés, MD, PhD^3,8,14,15*, Ascensión López-Díaz De Cerio^8,14,15,16*, Mikel Hernaez, PhD^8,14,17,18*, Felipe Prosper, MD, PhD^3,4,5,13,14 and Juan Roberto Rodriguez-Madoz, PhD^5,8,14*

¹Hematology Department. Hospital Universitario de Navarra. IdisNA, Pamplona, Spain
²Hematology and Cell Therapy Department, Clinica Universidad de Navarra, IdiSNA., Pamplona, Spain
³Hematology and Cell Therapy Department. Clinica Universidad de Navarra, IdiSNA., Pamplona, Spain
⁴Centro de Investigacion Biomedica en Red de Cancer (CIBERONC), Madrid, Spain
⁵Hemato-Oncology Program. Cima Universidad de Navarra. IdiSNA., Pamplona, Spain
⁶Computational Biology Program. Cima Universidad de Navarra. IdiSNA., Pamplona, Spain
⁷Hemato-Oncology Program. Cima Universidad de Navarra. IdiSNA, Pamplona, Spain
⁸Centro de Investigacion Biomedica en Red de Cancer (CIBERONC)., Madrid, Spain
⁹Hematology Department. Hospital Universitario de Navarra. IdisNA, Pamplona, ESP
¹⁰Hospital Universitario de Donostia, San Sebastian, Spain
¹¹Hematology and Cell Therapy Department, Clinica Universidad de Navarra, IdiSNA, Pamplona, Spain
¹²Immunology and Immunotherapy Program. Cima Universidad de Navarra. IdiSNA., Pamplona, Spain
¹³Cancer Center Universidad de Navarra (CCUN)., Pamplona, Spain
¹⁴Cancer Center Clinica Universidad de Navarra (CCUN)., Pamplona, Spain
¹⁵Immunology and Immunotherapy Department. Clinica Universidad de Navarra., Pamplona, Spain
¹⁶Clínica Universidad de Navarra. Centro de Investigación Médica Aplicada., Pamplona, Spain
¹⁷Data Science and Artificial Intelligence Institute (DATAI). Universidad de Navarra., Pamplona, Spain
¹⁸Computational Biology Program. Cima Universidad de Navarra. IdiSNA and Data Science and Artificial Intelligence Institute (DATAI), Universidad de Navarra, Pamplona, Spain

Sinéad Kinsella, MSc, PhD^1*, Colton W Smith^2*, Kelly McKenna^3*, Menna Hailemariam^4*, Francesco Mazziotta^5*, Lauren E Martin^4*, Shihong Zhang^4*, Tzu-Hao Tang^4*, Jonathan Linton^4*, Thomas M Schmitt^1*, Anthony Rongvaux^1* and Aude G Chapuis, MD³

¹Fred Hutchinson Cancer Research Center, Seattle, WA
²Fred hutchinson Cancer Center, Seattle
³Fred Hutchinson Cancer Center, Seattle, WA
⁴Fred Hutchinson Cancer Center, Seattle
⁵Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins, Baltimore, MD, Johns Hopkins University School of Medicine, Baltimore, MD, Baltimore, MD

Kanagaraju Ponnusamy, PhD, MSc, BSc^1*, Lyra Randzavola, PhD^2*, Hongwei Ren, MD, PhD^2*, Klesti Karaxhuku, MSc, BSc^1*, Bryan Lye, M. Phil^2*, Dimitrios Leonardos^1,3*, Reza Nadafi^4*, Irene Sarkar^4*, Ilia Leontari^1*, Farah Sabrin^2*, Mehmood Zaidi^2*, Marco Bua^5*, Maria Atta^1*, Alexia Katsarou^1*, Irene Roberts, MD^6,7, Aristeidis Chaidos, MD, PhD^1,5* and Anastasios Karadimitris, MD, PhD^1,5*

¹Hugh & Josseline Langmuir Centre for Myeloma Research Centre for Haematology, Department of Immunology and Inflammation, Imperial College London, London, United Kingdom
²Centre for Haematology, Department of Immunology and Inflammation, Imperial College London, London, United Kingdom
³University of Ioannina Medical School, Ioannina, Greece
⁴Lumicks, Amsterdam, Netherlands
⁵Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom
⁶Department of Paediatrics, University of Oxford, Oxford, United Kingdom
⁷Molecular Haematology Unit, MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, United Kingdom

Bartosz Grzywacz, MD¹, Ashenafi Tilahun^1*, Irena Wilson^1*, Kevin Welk^1*, Bruce R Blazar, MD² and Christopher A Pennell, PhD¹

¹Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, MN
²Division of Pediatric Blood and Marrow Transplantation, University of Minnesota, Minneapolis, MN

Jason Yokoyama, BS^1*, Allan Wang^1*, Maria Steele^1*, John Crowl^1*, Thaddeus Davenport^1*, Jared Hammer^1*, Willimark Obenza^1*, Vanessa Montoya^1*, Robin Kirkpatrick^1*, Laura Baker^1*, Tina Tan^1*, Emily Bringgold^1*, Kristie Shirley^1*, Maanasee Deshmukh^1*, Bradley Hammerson^1*, Paul Sample^1*, Brian Weitzner^1*, Shujun Yuan^1*, Aaron Foster¹, Marc Lajoie^1*, Scott Boyken^1*, Howell Moffett^2* and Rupesh Amin^1*

¹Outpace Bio, Seattle
²Outpace Bio, Seattle, WA

Adam E. Snook, PhD^1,2*, Ruchi P. Patel, MS^3,4,5, Guido Ghilardi, MD^4,5,6*, Aditya Nimmagadda^2*, Steven Yang^2*, Dean Qian^2*, Patrizia Porazzi, PhD^4,5,6*, Rosemary Mazanet, MD, PhD², Stephen J Schuster, MD^4,5,6, Stefan K. Barta, MD^4,5,6, Trang Vu^2*, Marco Ruella, MD^3,7,8 and Nicholas A. Siciliano, PhD^2*

¹Department of Pharmacology, Physiology, and Cancer Biology, Thomas Jefferson University, Philadelphia, PA
²Vittoria Biotherapeutics, Philadelphia, PA
³Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA
⁴Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
⁵Division of Hematology-Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA
⁶Center for Cellular Immunotherapies, University of Pennsylvania, Philadelphia, PA
⁷Lymphoma Program, University of Pennsylvania, Philadelphia, PA
⁸Department of Medicine, Division of Hematology/Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA

Paul Lin, MD, PhD¹, Francia C. Reyes Silva^1*, Pei Lin, MD, DM, MDPC², April L. Gilbert^1*, Sunil Acharya, PhD^1*, Ana K. Nunez Cortes, MD^1*, Pinaki Banerjee, PhD^1*, Dexing Fang^1*, Luciana Melo Garcia, MD, MSc¹, May Daher, MD¹, Rafet Basar, MD^1*, Krina K. Patel, MD, MSc³, Hans Lee, MD⁴, Robert Z. Orlowski, MD, PhD⁴, Hind Rafei, MD¹, David Marin, MD¹, Richard E. Champlin, MD¹, Elizabeth J. Shpall, MD¹ and Katy Rezvani, MD¹

¹Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX
³University of Texas MD Anderson Cancer Center, Houston, TX
⁴Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX

Prabesh Khatiwada, PhD^1*, Mithil Soni, PhD^2* and Pawel Muranski, MD³

¹Columbia Center for Translational Immunology, Columbia University Irving Medical Center, New York, NY
²Columbia Center for Translational Immunology, Columbia University Irving Medical Center, New York City, NY
³Columbia Center for Translational Immunology, Columbia University Irving Medical Center, Chevy Chase, MD